GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BeOne Medicines Ltd (BSP:B1ME34) » Definitions » E10

BeOne Medicines (BSP:B1ME34) E10 : R$-2.92 (As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is BeOne Medicines E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

BeOne Medicines's adjusted earnings per share data for the three months ended in Dec. 2024 was R$0.000. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is R$-2.92 for the trailing ten years ended in Dec. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2025-03-03), BeOne Medicines's current stock price is R$66.48. BeOne Medicines's E10 for the quarter that ended in Dec. 2024 was R$-2.92. BeOne Medicines's Shiller PE Ratio of today is .


BeOne Medicines E10 Historical Data

The historical data trend for BeOne Medicines's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BeOne Medicines E10 Chart

BeOne Medicines Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - -2.23 -2.92

BeOne Medicines Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.23 -2.35 -2.65 -2.65 -2.92

Competitive Comparison of BeOne Medicines's E10

For the Biotechnology subindustry, BeOne Medicines's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BeOne Medicines's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BeOne Medicines's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where BeOne Medicines's Shiller PE Ratio falls into.



BeOne Medicines E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, BeOne Medicines's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=0/133.1571*133.1571
=0.000

Current CPI (Dec. 2024) = 133.1571.

BeOne Medicines Quarterly Data

per share eps CPI Adj_EPS
201503 -0.024 99.621 -0.032
201506 -0.013 100.684 -0.017
201509 -0.041 100.392 -0.054
201512 -0.134 99.792 -0.179
201603 -0.135 100.470 -0.179
201606 -0.107 101.688 -0.140
201609 -0.135 101.861 -0.176
201612 -0.127 101.863 -0.166
201703 -0.163 102.862 -0.211
201706 -0.206 103.349 -0.265
201709 0.326 104.136 0.417
201712 -0.287 104.011 -0.367
201803 -0.273 105.290 -0.345
201806 -0.431 106.317 -0.540
201809 -0.406 106.507 -0.508
201812 -0.707 105.998 -0.888
201903 -0.439 107.251 -0.545
201906 -0.221 108.070 -0.272
201909 -0.835 108.329 -1.026
201912 -1.046 108.420 -1.285
202003 -0.919 108.902 -1.124
202006 -0.890 108.767 -1.090
202009 -1.039 109.815 -1.260
202012 -1.070 109.897 -1.296
202103 0.147 111.754 0.175
202106 -1.052 114.631 -1.222
202109 -0.997 115.734 -1.147
202112 -1.382 117.630 -1.564
202203 -0.854 121.301 -0.937
202206 -1.102 125.017 -1.174
202209 -1.118 125.227 -1.189
202212 -0.900 125.222 -0.957
202303 -0.704 127.348 -0.736
202306 -0.707 128.729 -0.731
202309 0.385 129.860 0.395
202312 -0.688 129.419 -0.708
202403 -0.492 131.776 -0.497
202406 -0.252 132.554 -0.253
202409 -0.259 133.029 -0.259
202412 0.000 133.157 0.000

Add all the adjusted EPS together and divide 10 will get our e10.


BeOne Medicines  (BSP:B1ME34) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


BeOne Medicines E10 Related Terms

Thank you for viewing the detailed overview of BeOne Medicines's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


BeOne Medicines Business Description

Address
c/o Mourant Governance Services (Cayman) Limited, 94 Solaris Avenue, Camana Bay, Grand Cayman, CYM, KY1-1108
Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeiGene is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeiGene runs global clinical trials with its own team. As of 2023, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 50% of BeiGene's revenue.

BeOne Medicines Headlines

No Headlines